tiprankstipranks
Trending News
More News >
Y-Mabs Therapeutics (YMAB)
NASDAQ:YMAB
US Market

Y-Mabs Therapeutics (YMAB) Revenue

Compare
509 Followers

Y-Mabs Therapeutics Revenue

Y-Mabs Therapeutics had a revenue of 26.50M in the quarter ending Dec 31, 2024, with 43.52%. This bring the company's revenue in the last twelve months to 87.69M, Decreased 3.70%. In the fiscal year ending Dec 31, 2024, Y-Mabs Therapeutics had annual revenue of 87.69M with 3.38% growth.
Revenue (ttm)
87.69M
Revenue Growth
3.38%
P/S Ratio
2.54
Revenue/Employee
$843,125
Employees
104
Market Cap
$222.93M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 202487.69M2.87M+3.38%
Dec 31, 202384.82M19.55M+29.96%
Dec 31, 202265.27M30.37M+87.03%
Dec 31, 202134.90M14.15M+68.18%
Dec 31, 202020.75M+∞%
Dec 31, 20190.00
Dec 31, 20180.00
Dec 31, 20170.00
Dec 31, 20160.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis